Sample
Serum, plasma or other body fluids
Intended Use
This enzyme immunoassay kit is suited for measuring IGFBP-2 in human serum, plasma or in other body fluids, for example, cerebrospinal fluid, breast milk, amniotic fluid, saliva, as for scientific purposes. It is also suited to quantitate IGFBP-2 in cell culture media.
Contents of Kit
1. Microtiter plate: ready for use, coated with mouse-anti-hIGFBP-2-antibody. Wells are separately breakable. (8x12) wells
2. Calibrators (CAL A-E): lyophilized, (recombinant human IGFBP-2), concentrations are given on vial labels and on quality certificate. 5 x 750 μL
3. Control 1 (CTR1): lyophilized, (human serum), concentration is given on quality certificate. 1 x 100 μL
4. Control 2 (CTR2): lyophilized, (human serum), concentration is given on quality certificate. 1 x 100 μL
5. Antibody-HRP-Conjugate (DET): ready for use, contains rabbit biotinylated anti-hIGFBP-2 antibody + streptavidin horseradish peroxidase conjugate. 1 x 12 mL
6. Dilution Buffer (DIL): ready for use. 1 x 50 mL
7. Washing Buffer (WB): 20-fold concentrated solution. 1 x 50 mL
8. Substrate (S): ready for use, horseradish-peroxidase-(HRP) substrate, stabilised Tetramethylbencidine. 1 x 12 mL
9. Stopping Solution (STP): ready for use, 0.2 M sulfuric acid. 1 x 12 mL
10. Sealing Tape: for covering the microtiter plate. 2
Storage
Store the kit at 2-8°C after receipt until its expiry date. The lyophilized reagents should be stored at –20 °C after reconstitution. Avoid repeated thawing and freezing.
The shelf life of the components after initial opening is warranted for 4 weeks, store the unused strips and microtiter wells airtight together with the desiccant at 2-8°C in the clip-lock bag, use in the frame provided. The reconstituted components Calibrators A-E and Controls CTR1 and CTR2 must be stored at –20°C (max. 4 weeks). For further use, thaw quickly but gently (avoid temperature increase above room temperature and avoid excessive vortexing). Up to 3 of the freeze-thaw cycles did not influence the assay. The 1:20 diluted Washing Buffer WP is 4 weeks stable at 2-8°C
Precision
The inter- and intra assay coefficients of variability are below 10%.
Sensitivity
Sensitivity was assed by measuring the blank and calculating the theoretical concentration of the blank + 2SD. The analytical sensitivity of the Human IGFBP-2 ELISA Kit is 0.2 ng/mL.
General Description
Insulin-like growth factors (IGFs) regulate the proliferation, differentation, apoptose, cell adhesion and metabolism in various tissues and cell types. The IGF-I, which is produced mainly in liver under the influence of growth hormone (GH), regulates as hormone the linear growth of the bones and the process of sexual maturity, while IGF-II is mainly a growth factor of fetal tissue. The biological actions of IGF over the IGF-Type-I receptor are modulated variably through the IGF binding proteins (IGFBP-1 to-6). IGFBP-2 is, after IGFBP-3, the second most frequent IGFBP in the human blood. IGFs, especially tumor typical pro-IGF-forms and hormones regulate the expression of IGFBP-2, GH effect is thereby inhibiting. At cellular level IGFBP-2 seems to stimulate the proliferation and dissemination of solid tumors via an IGF-independent mechanism. IGFBP-2 is a unglycosylated polypetide of 31.3 kDa, which forms binary IGF-complexes and shows no circadian rhythm in the circulation.The serum concentration of IGFBP-2 increases in fasting, after major surgery and after trauma, but the increasing of the concentration is most intensive in malignant diseases. The correlation of the IGFBP-2 level to the degree of progression is a striking feature in various tumor types as is the normalization of the IGFBPserum levels after remission. During the GH-therapy, e.g. in short stature and in GHabuse (doping) the IGFBP-2 level decreases. In Trisomy 18 IGFBP-2 in maternal serum is decreased and IGFBP-1 is increased; therefore the ratio IGFBP-2 /IGFBP-1 is a marker for this chromosome abnormality.
Standard Curve
The exemplary shown calibration curve in Figure below cannot be used for calculation of your test results. You have to establish a calibration curve for each test you conduct!

Citations
Publication ()
Have you cited DEIA-NB24-12 in a publication?
Let us know and earn a reward for your research.